• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类膀胱移行细胞癌在肿瘤进展过程中获得功能性Fas配体。

Human urinary bladder transitional cell carcinomas acquire the functional Fas ligand during tumor progression.

作者信息

Chopin Dominique, Barei-Moniri Reza, Maillé Pascale, Le Frère-Belda Marie-Aude, Muscatelli-Groux Béatrice, Merendino Nicolò, Lecerf Laure, Stoppacciaro Antonella, Velotti Francesca

机构信息

Service d'Urologie et Groupe d'Etude des Tumeurs Urologiques Equipe Mixte INSERM 03-37, Centre Hôspitalier Universitaire Henri Mondor, Créteil, France.

出版信息

Am J Pathol. 2003 Apr;162(4):1139-49. doi: 10.1016/S0002-9440(10)63910-7.

DOI:10.1016/S0002-9440(10)63910-7
PMID:12651606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1851234/
Abstract

The interaction between FasL on tumor cells and Fas on lymphocytes may represent a tumor immune escape mechanism. We explored FasL expression and function in human urinary bladder transitional cell carcinomas (TCCs). FasL expression was observed in situ in 45% of TCCs (n = 45) and was absent in normal urothelium (n = 20). A correlation existed between FasL expression and high tumor grade (0% in G1, 14% in G2, and 75% in G3; P < 0.0001) and stage (13% in superficial Ta-T1 versus 81% in invasive T2-T4; P < 0.0001). FasL function was shown by the ability of two FasL-positive primary culture TCC cell lines (established from two FasL-positive invasive TCCs) to induce Fas-mediated killing not only of conventional Fas-sensitive targets (such as Jurkat cells or phytohemagglutinin-lymphoblasts), but also of autologous T lymphocytes generated in a mixed lymphocyte tumor-cell culture. In addition, an association between FasL expression by TCC cells and activated caspase-8, -9, and -3 expression by interferon-gamma-producing CD8-positive tumor-infiltrating lymphocytes was observed in situ. Our results show a functional expression of TCC-expressed FasL that correlates with tumor progression. These results suggest that TCC-expressed FasL may induce apoptosis of anti-tumor T lymphocytes in vivo, providing new insights on the mechanisms involved in bladder TCC progression.

摘要

肿瘤细胞上的FasL与淋巴细胞上的Fas之间的相互作用可能代表一种肿瘤免疫逃逸机制。我们探讨了FasL在人膀胱移行细胞癌(TCC)中的表达及功能。在45%的TCC(n = 45)中观察到FasL原位表达,而在正常尿路上皮(n = 20)中未观察到。FasL表达与高肿瘤分级(G1中为0%,G2中为14%,G3中为75%;P < 0.0001)和分期(浅表Ta-T1期为13%,浸润性T2-T4期为81%;P < 0.0001)相关。两个FasL阳性的原代培养TCC细胞系(由两个FasL阳性的浸润性TCC建立)不仅能够诱导Fas介导的对传统Fas敏感靶细胞(如Jurkat细胞或植物血凝素淋巴细胞)的杀伤,还能诱导在混合淋巴细胞肿瘤细胞培养中产生的自体T淋巴细胞的杀伤,这表明了FasL的功能。此外,原位观察到TCC细胞FasL表达与产生干扰素-γ的CD8阳性肿瘤浸润淋巴细胞中活化的caspase-8、-9和-3表达之间存在关联。我们的结果显示TCC表达的FasL具有与肿瘤进展相关的功能性表达。这些结果表明TCC表达的FasL可能在体内诱导抗肿瘤T淋巴细胞凋亡,为膀胱TCC进展所涉及的机制提供了新的见解。

相似文献

1
Human urinary bladder transitional cell carcinomas acquire the functional Fas ligand during tumor progression.人类膀胱移行细胞癌在肿瘤进展过程中获得功能性Fas配体。
Am J Pathol. 2003 Apr;162(4):1139-49. doi: 10.1016/S0002-9440(10)63910-7.
2
Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.Fas配体在人头颈鳞状细胞癌中表达,并促进T淋巴细胞凋亡。
Cancer Res. 1999 Oct 15;59(20):5356-64.
3
c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.膀胱尿路上皮癌中c-FLIP的表达:其在对Fas介导的凋亡的抗性中的作用及临床病理相关性。
Urology. 2004 Jun;63(6):1198-204. doi: 10.1016/j.urology.2004.01.007.
4
Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?蕈样肉芽肿中肿瘤性T淋巴细胞表达Fas配体介导CD8 + 细胞毒性T淋巴细胞的清除:肿瘤免疫逃逸的一种潜在机制?
Clin Cancer Res. 2001 Sep;7(9):2682-92.
5
Fas ligand and TNF-related apoptosis-inducing ligand induction on infiltrating lymphocytes in bladder carcinoma by bacillus Calmette-Guérin treatment.卡介苗治疗对膀胱癌浸润淋巴细胞上Fas配体和肿瘤坏死因子相关凋亡诱导配体的诱导作用
Urol Int. 2005;75(1):80-7. doi: 10.1159/000085934.
6
Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.膀胱移行细胞癌中Rb和p16肿瘤抑制基因以及CDK4的mRNA表达改变与肿瘤进展相关。
Anticancer Res. 2004 Mar-Apr;24(2B):1011-23.
7
Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.膀胱移行细胞癌中血管内皮生长因子及血管生成素-1和-2通路的改变与肿瘤进展相关。
Anticancer Res. 2004 Sep-Oct;24(5A):2745-56.
8
Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.肾细胞癌患者肿瘤浸润淋巴细胞与外周淋巴细胞中Fas及Fas配体的差异表达
Anticancer Res. 2003 Jan-Feb;23(1A):433-7.
9
Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.在小细胞肺癌中FasL过表达的人类肺肿瘤中,Fas表达和功能频繁丧失。
J Pathol. 2003 Oct;201(2):268-77. doi: 10.1002/path.1428.
10
Superantigen-activated mononuclear cells induce apoptosis in transitional cell carcinoma.超抗原激活的单核细胞诱导移行细胞癌凋亡。
Anticancer Res. 2005 Sep-Oct;25(5):3565-73.

引用本文的文献

1
BCG therapy in bladder cancer and its tumor microenvironment interactions.卡介苗治疗膀胱癌及其与肿瘤微环境的相互作用。
Clin Microbiol Rev. 2025 Jun 12;38(2):e0021224. doi: 10.1128/cmr.00212-24. Epub 2025 Mar 20.
2
Targeted therapies in bladder cancer: signaling pathways, applications, and challenges.膀胱癌的靶向治疗:信号通路、应用及挑战
MedComm (2020). 2023 Dec 15;4(6):e455. doi: 10.1002/mco2.455. eCollection 2023 Dec.
3
Immune escape mechanisms and immunotherapy of urothelial bladder cancer.尿路上皮膀胱癌的免疫逃逸机制与免疫治疗
J Clin Transl Res. 2021 Jul 30;7(4):485-500. eCollection 2021 Aug 26.
4
Emphasis of FAS/FASL gene polymorphism in patients with non-muscle invasive bladder cancer.非肌层浸润性膀胱癌患者中FAS/FASL基因多态性的研究重点
Ir J Med Sci. 2018 Nov;187(4):1115-1119. doi: 10.1007/s11845-018-1764-7. Epub 2018 Feb 16.
5
The role of CD95 and CD95 ligand in cancer.CD95和CD95配体在癌症中的作用。
Cell Death Differ. 2015 Apr;22(4):549-59. doi: 10.1038/cdd.2015.3. Epub 2015 Feb 6.
6
Capsaicin as an inducer of damage-associated molecular patterns (DAMPs) of immunogenic cell death (ICD) in human bladder cancer cells.辣椒素作为一种免疫原性细胞死亡(ICD)相关损伤模式分子(DAMPs)的诱导剂在人膀胱癌细胞中的作用。
Cell Stress Chaperones. 2013 Nov;18(6):801-8. doi: 10.1007/s12192-013-0422-2. Epub 2013 Apr 12.
7
Prognostic impact of apoptosis marker Fas (CD95) and its ligand (FasL) on bladder cancer in Egypt: study of the effect of schistosomiasis.凋亡标志物Fas(CD95)及其配体(FasL)对埃及膀胱癌的预后影响:血吸虫病作用的研究
Ecancermedicalscience. 2012;6:278. doi: 10.3332/ecancer.2012.278. Epub 2012 Nov 6.
8
Tissue expression of the proteins fas and fas ligand in colorectal cancer and liver metastases.fas蛋白和fas配体在结直肠癌及肝转移灶中的组织表达情况
J Gastrointest Cancer. 2012 Jun;43(2):224-8. doi: 10.1007/s12029-011-9252-6.
9
The immunoregulatory mechanisms of carcinoma for its survival and development.肿瘤的免疫调控机制促进其生存和发展。
J Exp Clin Cancer Res. 2011 Jan 21;30(1):12. doi: 10.1186/1756-9966-30-12.
10
Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.聚焦肿瘤浸润淋巴细胞:肿瘤浸润淋巴细胞在人类膀胱癌中的预后意义
Cancer Immun. 2007 Jun 26;7:10.

本文引用的文献

1
Cytotoxic T lymphocytes: all roads lead to death.细胞毒性T淋巴细胞:条条大路通死亡。
Nat Rev Immunol. 2002 Jun;2(6):401-9. doi: 10.1038/nri819.
2
Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3.存档石蜡切片中凋亡细胞检测的改进:使用抗裂解型半胱天冬酶3抗体的免疫组织化学法
J Histochem Cytochem. 2002 Apr;50(4):449-54. doi: 10.1177/002215540205000401.
3
Significance of serum soluble Fas ligand in patients with bladder carcinoma.血清可溶性Fas配体在膀胱癌患者中的意义。
Cancer. 2001 Jul 15;92(2):287-93. doi: 10.1002/1097-0142(20010715)92:2<287::aid-cncr1321>3.0.co;2-4.
4
Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation.膀胱癌细胞在恶性转化过程中获得了逃避Fas介导的凋亡和免疫监视的有效机制。
Br J Cancer. 2001 May 18;84(10):1330-8. doi: 10.1054/bjoc.2001.1808.
5
Flow cytometric determination of intracellular or secreted IFNgamma for the quantification of antigen reactive T cells.通过流式细胞术检测细胞内或分泌的干扰素γ以定量抗原反应性T细胞。
J Immunol Methods. 2001 May 1;251(1-2):101-8. doi: 10.1016/s0022-1759(01)00312-x.
6
Immune privilege or inflammation? Insights into the Fas ligand enigma.免疫豁免还是炎症?对Fas配体之谜的见解。
Nat Med. 2001 Mar;7(3):271-4. doi: 10.1038/85395.
7
Cytolytic T lymphocytes raised against a human bladder carcinoma recognize an antigen encoded by gene MAGE-A12.
J Immunol. 2000 Jun 1;164(11):6041-5. doi: 10.4049/jimmunol.164.11.6041.
8
Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.人类实体瘤逃避T细胞识别:分子机制与功能意义
Adv Immunol. 2000;74:181-273. doi: 10.1016/s0065-2776(08)60911-6.
9
Transitional cell carcinoma expresses high levels of Fas ligand in vivo.移行细胞癌在体内表达高水平的Fas配体。
BJU Int. 1999 Apr;83(6):698-702. doi: 10.1046/j.1464-410x.1999.00975.x.
10
The Fas counterattack: cancer as a site of immune privilege.Fas反击:癌症作为免疫豁免部位
Immunol Today. 1999 Jan;20(1):46-52. doi: 10.1016/s0167-5699(98)01382-6.